Evidence map›Paper›PMID 37063447›Full record

ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2023

Translating and piloting a cardiovascular risk assessment and management online tool using mobile technology.

Monica Zolezzi, Athar Elhakim, Taimaa Hejazi, Lana Kattan, Dana Mustafa, Shimaa Aboelbaha, Shorouk Homs, Yazid N Al Hamarneh

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Monica ZolezziCollege of Pharmacy, QU Health, Qatar University, Doha, Qatar.
Athar ElhakimCollege of Health Sciences, University of Doha for Science and Technology, Doha, Qatar.
Taimaa HejaziCollege of Pharmacy, QU Health, Qatar University, Doha, Qatar.
Lana KattanCollege of Pharmacy, QU Health, Qatar University, Doha, Qatar.
Dana MustafaCollege of Pharmacy, QU Health, Qatar University, Doha, Qatar.
Shimaa AboelbahaCollege of Pharmacy, QU Health, Qatar University, Doha, Qatar.
Shorouk HomsCollege of Pharmacy, QU Health, Qatar University, Doha, Qatar.
Yazid N Al HamarnehUniversity of Alberta, Edmonton, Alberta, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cardiovascular disease (CVD) risk assessment and management (RAM) services face many challenges and barriers in the community. Mobile technology offers the opportunity to empower patients and improve access to health prevention strategies to overcome these barriers. However, there is limited information on the availability and use of CVDRAM-related mobile technology in the Arabic language. Objectives: To pilot test an Arabic version of a CVDRAM application among potential end-users accessing community pharmacy services in Qatar. Methodology: Translation of an established cardiovascular risk calculator ( Results: A total of 10 CRxs and 5 MOP were interviewed. Five themes emerged to describe the Conclusion: End-users of the

Indexed as

Cardiovascular riskCommunity pharmacistsMobile technologyPatient educationPilot testing

Identifiers

PMID37063447
PMCPMC10102547

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.